Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012786 |
---|---|
Receipt number | R000014925 |
Scientific Title | Randomized phase II study of docetaxel + bevacizumab or pemetrexed + bevacizumab for elderly non-squamous non-small-cell lung cancer. (TORG1323) |
Date of disclosure of the study information | 2014/01/11 |
Last modified on | 2020/04/21 13:56:19 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/01/08 10:53:51 | ||
2 | Update | 2014/03/03 14:51:34 | Recruitment status |
|
3 | Update | 2014/07/08 09:21:42 | Name of person sending information Name of person sending information |
|
4 | Update | 2017/01/10 09:16:46 | Name of primary person or sponsor Organization |
|
5 | Update | 2017/12/11 09:24:46 | Recruitment status Last follow-up date |
|
6 | Update | 2018/01/11 09:09:37 | Date of closure to data entry |
|
7 | Update | 2018/05/17 09:26:45 | Date analysis concluded |
|
8 | Update | 2019/04/24 09:13:27 | Recruitment status Date of IRB |
|
9 | Update | 2020/04/21 13:56:19 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |